Shares of Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV – Get Free Report) fell 46.8% during mid-day trading on Monday . The company traded as low as $0.31 and last traded at $0.31. 1,399 shares were traded during mid-day trading, an increase of 18% from the average session volume of 1,183 shares. The stock had previously closed at $0.59.
Mosaic ImmunoEngineering Trading Down 46.8 %
The business has a fifty day simple moving average of $0.56 and a 200 day simple moving average of $0.56.
Mosaic ImmunoEngineering Company Profile
Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.
See Also
- Five stocks we like better than Mosaic ImmunoEngineering
- The How and Why of Investing in Biotech Stocks
- Unbearably Good Investment: A Build-A-Bear Stock Analysis
- What Are the FAANG Stocks and Are They Good Investments?
- Coinbase Stock Tempting but isn’t without its Risks
- How to Calculate Retirement Income: MarketBeat’s Calculator
- This Industrial Products Stock is Goldman’s Favorite This Cycle
Receive News & Ratings for Mosaic ImmunoEngineering Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mosaic ImmunoEngineering and related companies with MarketBeat.com's FREE daily email newsletter.